Table 1 Comorbidities and clinical characteristics of patients who underwent open and endovascular aortic repair.
| Open repair, N=453 | Endovascular repair, N=189 | P value | |
|---|---|---|---|
| Age, years, mean±SD | 70.8±7.9 | 77.5±7.6 | <0.01 |
| Male sex | 85.9% (389/453) | 84.1% (159/189) | 0.57 |
| Marfan syndrome | 0.9% (4/453) | 0% (0/189) | 0.45 |
| History of aortic dissection | 7.3% (33/453) | 1.6% (3/189) | <0.01 |
| Hypertension | 81.9% (371/453) | 79.4% (150/189) | 0.45 |
| Diabetes | 19.6% (89/453) | 11.6% (22/189) | 0.014 |
| Dyslipidemia | 44.2% (200/453) | 43.4% (82/189) | 0.86 |
| COPD | 10.2% (46/453) | 16.9% (32/189) | 0.017 |
| History of smoking | 75.7% (343/453) | 75.7% (143/189) | 0.98 |
| History of ischemic heart disease | 37.3% (169/453) | 40.2% (76/189) | 0.49 |
| History of cerebrovascular disease | 13.0% (59/453) | 9.0% (17/189) | 0.15 |
| Peripheral artery disease | 4.2% (19/453) | 2.1% (4/189) | 0.29 |
| Left ventricular ejection fraction<50% | 4.0% (18/453) | 1.1% (2/189) | 0.097 |
| Max diameter (mm), mean±SD | 51.0±11.7 | 52.1±9.2 | 0.28 |
| Mycotic aneurysm | 0.9% (4/453) | 0% (0/189) | 0.45 |
| Inflammatory aneurysm | 3.3% (15/453) | 1.6% (3/189) | 0.34 |
| Hypogastric artery aneurysm | 16.8% (76/453) | 9.5% (18/189) | 0.018 |
| Laboratory data | |||
| White blood cell (g/µL), mean±SD | 6,486±4,862 | 5,826±1,606 | 0.069 |
| Hemoglobin (g/dL), mean±SD | 12.9±1.8 | 12.5±1.9 | 0.029 |
| Hematocrit (%), mean±SD | 38.4±5.2 | 37.9±5.0 | 0.30 |
| Platelet (×103/µL), mean±SD | 20.9±6.1 | 19.9±5.8 | 0.37 |
| Albumin (g/mL), mean±SD | 4.1±0.6 | 4.0±0.6 | 0.52 |
| Creatinine (mg/dL), mean±SD | 1.0±0.5 | 1.0±0.4 | 0.39 |
| eGFR (mL/min/1.73 m2), mean±SD | 63.1±35.5 | 61.4±18.4 | 0.52 |
| eGFR <60 mL/min/1.73 m2 | 45.4% (205/453) | 48.7% (92/189) | 0.44 |
SD: standard deviation; COPD: chronic obstructive pulmonary disease; eGFR: estimated glomerular filtration rate